rs79879393

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000168.6(GLI3):​c.368-19G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0103 in 1,417,012 control chromosomes in the GnomAD database, including 103 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0084 ( 11 hom., cov: 32)
Exomes 𝑓: 0.011 ( 92 hom. )

Consequence

GLI3
NM_000168.6 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.405

Publications

3 publications found
Variant links:
Genes affected
GLI3 (HGNC:4319): (GLI family zinc finger 3) This gene encodes a protein which belongs to the C2H2-type zinc finger proteins subclass of the Gli family. They are characterized as DNA-binding transcription factors and are mediators of Sonic hedgehog (Shh) signaling. The protein encoded by this gene localizes in the cytoplasm and activates patched Drosophila homolog (PTCH) gene expression. It is also thought to play a role during embryogenesis. Mutations in this gene have been associated with several diseases, including Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome, preaxial polydactyly type IV, and postaxial polydactyly types A1 and B. [provided by RefSeq, Jul 2008]
GLI3 Gene-Disease associations (from GenCC):
  • Greig cephalopolysyndactyly syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics, Orphanet, Laboratory for Molecular Medicine, G2P
  • Pallister-Hall syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, G2P
  • polydactyly, postaxial, type A1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • polysyndactyly 4
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • tibial hemimelia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • acrocallosal syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • postaxial polydactyly type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 7-42076876-C-T is Benign according to our data. Variant chr7-42076876-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 137484.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00844 (1284/152212) while in subpopulation NFE AF = 0.0111 (752/68000). AF 95% confidence interval is 0.0104. There are 11 homozygotes in GnomAd4. There are 601 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 11 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000168.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GLI3
NM_000168.6
MANE Select
c.368-19G>A
intron
N/ANP_000159.3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GLI3
ENST00000395925.8
TSL:5 MANE Select
c.368-19G>A
intron
N/AENSP00000379258.3P10071
GLI3
ENST00000677605.1
c.368-19G>A
intron
N/AENSP00000503743.1P10071
GLI3
ENST00000678429.1
c.368-19G>A
intron
N/AENSP00000502957.1P10071

Frequencies

GnomAD3 genomes
AF:
0.00845
AC:
1285
AN:
152094
Hom.:
11
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00246
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.00969
Gnomad ASJ
AF:
0.0473
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00186
Gnomad FIN
AF:
0.00726
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0111
Gnomad OTH
AF:
0.0120
GnomAD2 exomes
AF:
0.00956
AC:
2393
AN:
250190
AF XY:
0.00943
show subpopulations
Gnomad AFR exome
AF:
0.00315
Gnomad AMR exome
AF:
0.00659
Gnomad ASJ exome
AF:
0.0521
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00602
Gnomad NFE exome
AF:
0.0115
Gnomad OTH exome
AF:
0.0116
GnomAD4 exome
AF:
0.0105
AC:
13313
AN:
1264800
Hom.:
92
Cov.:
19
AF XY:
0.0104
AC XY:
6677
AN XY:
639508
show subpopulations
African (AFR)
AF:
0.00212
AC:
63
AN:
29720
American (AMR)
AF:
0.00735
AC:
327
AN:
44466
Ashkenazi Jewish (ASJ)
AF:
0.0466
AC:
1162
AN:
24912
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38782
South Asian (SAS)
AF:
0.00283
AC:
233
AN:
82258
European-Finnish (FIN)
AF:
0.00587
AC:
313
AN:
53350
Middle Eastern (MID)
AF:
0.00931
AC:
50
AN:
5372
European-Non Finnish (NFE)
AF:
0.0113
AC:
10568
AN:
932064
Other (OTH)
AF:
0.0111
AC:
597
AN:
53876
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
600
1199
1799
2398
2998
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
392
784
1176
1568
1960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00844
AC:
1284
AN:
152212
Hom.:
11
Cov.:
32
AF XY:
0.00807
AC XY:
601
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.00246
AC:
102
AN:
41524
American (AMR)
AF:
0.00968
AC:
148
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0473
AC:
164
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5178
South Asian (SAS)
AF:
0.00166
AC:
8
AN:
4822
European-Finnish (FIN)
AF:
0.00726
AC:
77
AN:
10606
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0111
AC:
752
AN:
68000
Other (OTH)
AF:
0.0118
AC:
25
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
69
138
206
275
344
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0144
Hom.:
8
Bravo
AF:
0.00857
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not specified (3)
-
-
1
Pallister-Hall syndrome;C0265306:Greig cephalopolysyndactyly syndrome (1)
-
-
1
Pallister-Hall syndrome;C0265306:Greig cephalopolysyndactyly syndrome;C1868111:Polysyndactyly 4;C4282400:Polydactyly, postaxial, type A1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
2.2
DANN
Benign
0.23
PhyloP100
0.41
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs79879393; hg19: chr7-42116475; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.